The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Metabolic stress–induced activation of FoxO1 triggers diabetic cardiomyopathy in mice
Open accessAbstract
The leading cause of death in diabetic patients is cardiovascular disease; diabetic cardiomyopathy is typified by alterations in cardiac morphology and function, independent of hypertension or coronary disease. However, the molecular mechanism that links diabetes to cardiomyopathy is incompletely understood. Insulin resistance is a hallmark feature of diabetes, and the FoxO family of transcription factors, which regulate cell size, viability, and metabolism, are established targets of insulin and growth factor signaling. Here, we set out to evaluate a possible role of FoxO proteins in diabetic cardiomyopathy. We found that FoxO proteins were persistently activated in cardiac tissue in mice with diabetes induced either genetically or by high-fat diet (HFD). FoxO activity was critically linked with development of cardiomyopathy: cardiomyocyte-specific deletion of FoxO1 rescued HFD-induced declines in cardiac function and preserved cardiomyocyte insulin responsiveness. FoxO1-depleted cells displayed a shift in their metabolic substrate usage, from free fatty acids to glucose, associated with decreased accumulation of lipids in the heart. Furthermore, we found that FoxO1-dependent downregulation of IRS1 resulted in blunted Akt signaling and insulin resistance. Together, these data suggest that activation of FoxO1 is an important mediator of diabetic cardiomyopathy and is a promising therapeutic target for the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Role of diabetes in congestive heart failure: The Framingham study
Kannel, W. B., Hjortland, M., & Castelli, W. P. (1974) · The American Journal of Cardiology · doi:10.1016/0002-9149(74)90089-7 · Cited by 2,090
Ogg, S., Paradis, S., Gottlieb, S., Patterson, G. I., Lee, L., Tissenbaum, H. A., & Ruvkun, G. (1997) · Nature · doi:10.1038/40194 · Cited by 1,932
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,837
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress
Kops, G. J. P. L., Dansen, T. B., Polderman, P. E., Saarloos, I., Wirtz, K. W. A., Coffer, P. J., Huang, T.-T., Bos, J. L., Medema, R. H., & Burgering, B. M. T. (2002) · Nature · doi:10.1038/nature01036 · Cited by 1,580
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
Medema, R. H., Kops, G. J. P. L., Bos, J. L., & Burgering, B. M. T. (2000) · Nature · doi:10.1038/35008115 · Cited by 1,438
Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia
Eliasson, M. J. L., Sampei, K., Mandir, A. S., Hurn, P. D., Traystman, R. J., Bao, J., Pieper, A., Wang, Z.-Q., Dawson, T. M., Snyder, S. H., et al. (1997) · Nature Medicine · doi:10.1038/nm1097-1089 · Cited by 1,018
Self-citationInsulin signaling in health and disease
White, M. F. (2003) · Science · doi:10.1126/science.1092952 · Cited by 733 · cited 1×
“The hormone insulin is central to the control of intermediary metabolism, orchestrat - ing substrate utilization for storage or oxidation in all cells (28).”
Diabetic cardiomyopathy, causes and effects
Boudina, S., & Abel, E. D. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9131-7 · Cited by 728
Hyperglycemia-Induced Apoptosis in Mouse Myocardium
Cai, L., Li, W., Wang, G., Guo, L., Jiang, Y., & Kang, Y. J. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1938 · Cited by 662
Stahl, M., Dijkers, P. F., Kops, G. J. P. L., Lens, S. M. A., Coffer, P. J., Burgering, B. M. T., & Medema, R. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5024 · Cited by 585
Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis
Poornima, I. G., Parikh, P., & Shannon, R. P. (2006) · Circulation Research · doi:10.1161/01.res.0000207406.94146.c2 · Cited by 571
Current views on type 2 diabetes
Lin, Y., & Sun, Z. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0260 · Cited by 457
Insulin signaling meets mitochondria in metabolism
Cheng, Z., Tseng, Y., & White, M. F. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.06.005 · Cited by 449
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
An, D., & Rodrigues, B. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00278.2006 · Cited by 446
FoxO Transcription Factors Promote Autophagy in Cardiomyocytes
Sengupta, A., Molkentin, J. D., & Yutzey, K. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024406 · Cited by 428
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
Park, T.-S., Hu, Y., Noh, H.-L., Drosatos, K., Okajima, K., Buchanan, J., Tuinei, J., Homma, S., Jiang, X.-C., Abel, E. D., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800147-jlr200 · Cited by 411
The FOXO3a Transcription Factor Regulates Cardiac Myocyte Size Downstream of AKT Signaling
Skurk, C., Izumiya, Y., Maatz, H., Razeghi, P., Shiojima, I., Sandri, M., Sato, K., Zeng, L., Schiekofer, S., Pimentel, D., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500528200 · Cited by 353
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
HAYAT, S. A., PATEL, B., KHATTAR, R. S., & MALIK, R. A. (2004) · Clinical Science · doi:10.1042/cs20040057 · Cited by 352
Insulin-Resistant Cardiomyopathy
Witteles, R. M., & Fowler, M. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.021 · Cited by 351
Wende, A. R., & Abel, E. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.023 · Cited by 343
Foxo Transcription Factors Blunt Cardiac Hypertrophy by Inhibiting Calcineurin Signaling
Ni, Y. G., Berenji, K., Wang, N., Oh, M., Sachan, N., Dey, A., Cheng, J., Lu, G., Morris, D. J., Castrillon, D. H., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.637124 · Cited by 312
Self-citationAbnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.
Meyer, C., Stumvoll, M., Nadkarni, V, Dostou, J., Mitrakou, A., & Gerich, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2415 · Cited by 300
Serine/Threonine Phosphorylation of IRS-1 Triggers Its Degradation
Pederson, T. M., Kramer, D. L., & Rondinone, C. M. (2001) · Diabetes · doi:10.2337/diabetes.50.1.24 · Cited by 300
Ni, Y. G., Wang, N., Cao, D. J., Sachan, N., Morris, D. J., Gerard, R. D., Kuro-o, M., Rothermel, B. A., & Hill, J. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610290104 · Cited by 279
Self-citationLuiken, J. J. F. P., Koonen, D. P. Y., Willems, J., Zorzano, A., Becker, C., Fischer, Y., Tandon, N. N., van der Vusse, G. J., Bonen, A., & Glatz, J. F. C. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3113 · Cited by 260
Zhang, L., Keung, W., Samokhvalov, V., Wang, W., & Lopaschuk, G. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.014 · Cited by 257
Ouwens, D. M., Boer, C., Fodor, M., de Galan, P., Heine, R. J., Maassen, J. A., & Diamant, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1755-x · Cited by 256
Metabolic disturbances in diabetic cardiomyopathy.
Rodrigues, B. B., Cam, M. C., & McNeill, J. H. (1998) · PubMed · Cited by 248
Yan, J., Young, M. E., Cui, L., Lopaschuk, G. D., Liao, R., & Tian, R. (2009) · Circulation · doi:10.1161/circulationaha.108.832915 · Cited by 217
The FoxO Family in Cardiac Function and Dysfunction
Ronnebaum, S. M., & Patterson, C. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135931 · Cited by 206
Koitabashi, N., Bedja, D., Zaiman, A. L., Pinto, Y. M., Zhang, M., Gabrielson, K. L., Takimoto, E., & Kass, D. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.198416 · Cited by 203
Coort, S. L. M., Hasselbaink, D. M., Koonen, D. P. Y., Willems, J., Coumans, W. A., Chabowski, A., van der Vusse, G. J., Bonen, A., Glatz, J. F. C., & Luiken, J. J. F. P. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1655 · Cited by 202
Metabolic disturbances in diabetic cardiomyopathy
Rodrigues, B., Cam, M. C., & McNeill, J. H. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006882805197 · Cited by 197
Targeting Forkhead Box O1 from the Concept to Metabolic Diseases: Lessons from Mouse Models
Cheng, Z., & White, M. F. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3370 · Cited by 195
Ueno, M., Carvalheira, J. B. C., Tambascia, R. C., Bezerra, R. M. N., Amaral, M. E., Carneiro, E. M., Folli, F., Franchini, K. G., & Saad, M. J. A. (2005) · Diabetologia · doi:10.1007/s00125-004-1662-6 · Cited by 185
Long, Y. C., Cheng, Z., Copps, K. D., & White, M. F. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00983-10 · Cited by 180
Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding
Wright, J. J., Kim, J., Buchanan, J., Boudina, S., Sena, S., Bakirtzi, K., Ilkun, O., Theobald, H. A., Cooksey, R. C., Kandror, K. V., et al. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp017 · Cited by 173
Diabetic cardiomyopathy: mechanisms and therapeutic targets
Battiprolu, P. K., Gillette, T. G., Wang, Z. V., Lavandero, S., & Hill, J. A. (2010) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2010.08.001 · Cited by 144
Self-citationChronic Inhibition of Pyruvate Dehydrogenase in Heart Triggers an Adaptive Metabolic Response
Chambers, K. T., Leone, T. C., Sambandam, N., Kovács, A. D., Wagg, C. S., Lopaschuk, G. D., Finck, B. N., & Kelly, D. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.217349 · Cited by 131
Zhao, G., Jeoung, N. H., Burgess, S. C., Rosaaen-Stowe, K. A., Inagaki, T., Latif, S., Shelton, J. M., McAnally, J., Bassel‐Duby, R., Harris, R. A., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00870.2007 · Cited by 126
Self-citationFoxO, Autophagy, and Cardiac Remodeling
Ferdous, A., Battiprolu, P. K., Ni, Y. G., Rothermel, B. A., & Hill, J. A. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9200-z · Cited by 116
Self-citationAccuracy of echocardiographic estimates of left ventricular mass in mice
Collins, K. A., Korcarz, C. E., Shroff, S. G., et al. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.5.h1954 · Cited by 112
Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm
Chabowski, A., Coort, S. L., Calles-Escandón, J., Tandon, N. N., Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00573.2003 · Cited by 112
Aldose Reductase Induced by Hyperosmotic Stress Mediates Cardiomyocyte Apoptosis
Galvez, A. S., Ulloa, J. A., Chiong, M., Criollo, A., Eisner, V., Barros, L. F., & Lavandero, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211824200 · Cited by 107
Self-citationInsulin signaling regulating genes: effect on T2DM and cardiovascular risk
Prudente, S., Morini, E., & Trischitta, V. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.215 · Cited by 93
Guo, S., Dunn, S. L., & White, M. F. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0092 · Cited by 64
Diabetic cardiomyopathy: signaling defects and therapeutic approaches
Dobrin, J. S., & Lebeche, D. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.17 · Cited by 63
Insulin signaling in heart muscle: Lessons from genetically engineered mouse models
Abel, E. D. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0034-4 · Cited by 54
Modulation of myocardial metabolism: an emerging therapeutic principle
Horowitz, J. D., Chirkov, Y. Y., Kennedy, J. A., & Sverdlov, A. L. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328339f191 · Cited by 53
Remodeling of Early-Phase Repolarization
Wang, Y., Cheng, J., Joyner, R. W., Wagner, M. B., & Hill, J. A. (2006) · Circulation · doi:10.1161/circulationaha.106.615682 · Cited by 52
Self-citationPhosphatases at the Heart of FoxO Metabolic Control
Tremblay, M. L., & Giguère, V. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.01.004 · Cited by 50
Carley, A. N., & Kleinfeld, A. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182162 · Cited by 48
Wang, Y., Nishina, P. M., & Naggert, J. Κ. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0026 · Cited by 47
Diabetic cardiomyopathy: how much does it depend on AGE?
Montagnani, M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.121 · Cited by 35
Sex differences in energy metabolism and performance of teleost cardiac tissue
Battiprolu, P. K., Harmon, K. J., & Rodnick, K. J. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00379.2006 · Cited by 29
Self-citation
Cited by
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,807
Molecular mechanisms of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2014) · Diabetologia · doi:10.1007/s00125-014-3171-6 · Cited by 903
Pathological Ventricular Remodeling: Mechanisms: Part 1 of 2
Burchfield, J. S., Xie, M., & Hill, J. A. (2013) · Circulation · doi:10.1161/circulationaha.113.001878 · Cited by 766
Self-citationKenny, H. C., & Abel, E. D. (2019) · Circulation Research · doi:10.1161/circresaha.118.311371 · Cited by 660
Guo, S. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0327 · Cited by 623
Metadata
- Authors
- Battiprolu, P. K., Hojayev, B., Jiang, N., Wang, Z. V., Luo, X., Iglewski, M., Shelton, J. M., Gerard, R. D., Rothermel, B. A., Gillette, T. G., Lavandero, S., & Hill, J. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-03-01
- Volume
- 122
- Issue
- 3
- Pages
- 1109-1118
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1982380248
- Cited by
- 345
- References
- 59
- FWCI
- 8.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.